Evidence map›Paper›PMID 37587850›Full record

ArticleJournal of psychosocial oncology2024

Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic.

Rachel Telles, Sharaf Zia, Breanna B Greteman, Premal H Thaker, Frank Penedo, Mary E Charlton, Michael J Goodheart, Jessica S Armer, Alyssa Noble, Anil K Sood and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of psychosocial oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rachel TellesDepartment of Psychological & Brain Sciences, University of Iowa, Iowa City, IA, USA.ORCID 0000-0003-0327-8326
Sharaf ZiaInstitute of Clinical and Translational Sciences, University of Iowa Hospital & Clinics, Iowa City, IA, USA.
Breanna B GretemanDepartment of Epidemiology, University of Iowa College of Public Health, Iowa City, IA, USA.
Premal H ThakerDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, Saint Louis, MO, USA.
Frank PenedoSylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Mary E CharltonDepartment of Epidemiology, University of Iowa College of Public Health, Iowa City, IA, USA.
Michael J GoodheartDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USA.
Jessica S ArmerDepartment of Psychological & Brain Sciences, University of Iowa, Iowa City, IA, USA.
Alyssa NobleDepartment of Psychological & Brain Sciences, University of Iowa, Iowa City, IA, USA.
Anil K SoodDepartments of Gynecologic Oncology, Cancer Biology and Center for RNA Interference and Noncoding RNA, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Susan K LutgendorfDepartment of Psychological & Brain Sciences, University of Iowa, Iowa City, IA, USA.
University of Iowa · USThe University of Texas MD Anderson Cancer Center · USUniversity of Miami · USWashington University in St. Louis · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Jon C.D. Houtman · 2000 to 2026
$70.0M
The University of Iowa Clinical and Translational Science AwardUL1TR002537 · NCATS · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R, WINOKUR, PATRICIA · 2018 to 2022
$20.0M
Harnessing the power of exosomes for non-coding RNA deliveryR35CA209904 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SOOD, ANIL K · 2017 to 2023
$5.0M
Ovarian Cancer: Mechanisms of Neuroendocrine RegulationR01CA109298 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SOOD, ANIL K · 2005 to 2017
$4.5M
Behavioral Influences on Ovarian Cancer Progression: Role of ChemoresistanceR01CA193249 · NCI · UNIVERSITY OF IOWA · PI LUTGENDORF, SUSAN K · 2016 to 2020
$3.2M
Living Well: A Web-based Intervention to Improve Quality of Life in Rural and Urban Ovarian Cancer SurvivorsR01CA246540 · NCI · UNIVERSITY OF IOWA · PI LUTGENDORF, SUSAN K · 2020 to 2024
$3.0M
Mechanisms of Health and Disease at the Behavioral-Biomedical InterfaceT32GM108540 · NIGMS · UNIVERSITY OF IOWA · PI LUTGENDORF, SUSAN K, VOSS, MICHELLE WEBB · 2014 to 2023
$1.7M
NCATS NIH HHS UL1 TR002537NCI NIH HHS P30 CA086862NCI NIH HHS R01 CA109298NCI NIH HHS R01 CA193249NCI NIH HHS R01 CA246540NCI NIH HHS R35 CA209904NIGMS NIH HHS T32 GM108540
6 · The paper itself

Abstract

objectiveThis study was designed to examine (1) whether ovarian cancer (OC) survivors would have greater well-being vs. elevated distress compared to community members during a universal health stressor (COVID-19) and (2) how resources and risk factors at diagnosis predicted vulnerability to a subsequent health-related stressor.

methodsOne hundred seventeen OC survivors were recruited from two academic medical centers and compared to a community-based sample on COVID-related distress and disruption. Latent class analysis identified differentially impacted groups of survivors.

resultsSurvivors reported lower distress than community members. Predictors of higher distress included shorter-term survivorship, greater disruption, and poorer emotional well--being (EWB) at diagnosis. Survivors were divided into high- and low-COVID-19-impact subgroups; high-impact individuals endorsed higher perceived stress and lower EWB at diagnosis.

conclusionSurvivors reported lower COVID-related distress than community participants. While depression at diagnosis did not predict later distress, EWB was a strong predictor of response to a novel health-related stressor.

Indexed as

Cancer SurvivorsCOVID-19Ovarian NeoplasmsStress, PsychologicalAdultAgedFemaleHumansMiddle AgedPsychological DistressRisk FactorsCOVID-19distressovarian cancerstresswell-being

Identifiers

PMID37587850
PMCPMC10873467
OpenAlexW4385897993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.